Thomas A. Dunlap.

ALBUQUERQUE, N.M.—WaveFront Dynamics Inc. (WDI), a venture-backed company and pioneer in wavefront sensing technology for use in measuring and perfecting visual performance, has announced the appointment of Thomas A. Dunlap to the board of directors. Dunlap is a senior executive with expertise in commercialization and business strategy in many ophthalmic medical device businesses, as well as experience in entrepreneurial ventures and multinational companies. “We are pleased to have Tom Dunlap join our board of directors," said WaveFront Dynamics’ founder and CEO, Dan Neal, PhD.

"Tom brings a wealth of ophthalmic industry leadership experience and will fit well with our existing team. He has extensive experience in the ophthalmic and broader medical industries at both large, well-established companies and innovative startups.”

Dunlap has held executive management positions at Mynosys Cellular Devices (Centricity Vision), Hoya Surgical Optics, Allergan Medical Optics (J&J Vision), Bausch + Lomb, American Hospital Supply Corporation, Surgilase, Inc. and Coherent, Inc. He brings experience as an independent board member, non-executive director, and chairman of the board with private ophthalmic medical device companies.

“I am honored to be appointed to the board of directors and excited about WaveFront Dynamics’ future, especially the significant opportunity launching the WaveDȳn Vision Analyzer in the United States," Dunlap stated. "Dan has set the company on strong footing with an incredibly strong team, and a novel device which will expand treatment options by providing diagnostic data to enhance patients’ quality of vision. We are well positioned to continue to deliver for patients and the physicians who serve them, while increasing value for our shareholders.”